U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950462) titled 'A Phase 1 Study of QLS7402 Injection in Adult Participants With Overweight or Obesity' on Nov. 10.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending dose of QLS7402 injection administered subcutaneously in adult participants with overweight or obesity
Study Start Date: Jan. 13, 2027
Study Type: INTERVENTIONAL
Condition:
Overweight or Obesity
Intervention:
DRUG: QLS7402 Injection
QLS7402 Injection
DRUG: Placebo control
Placebo Control
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shanghai Qilu Pharmaceutical Research and Deve...